Get started
Author

Shunichi Kouno

Observed name: S. Kouno
ORCID: 0000-0001-9329-1203
Observed ORCID: 0000-0001-9329-1203
OpenAlex ID: A5023511033
Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
2022 · Kazutaka Takehara, Yasuhiko Koga, et al. · Cells · 67
PDF
Predictive factors for progression‐free survival in non‐small cell lung cancer patients receiving nivolumab based on performance status
2019 · Yuichi Adachi, Akihiro Tamiya, et al. · Cancer Medicine · 57
Opioids impair nivolumab outcomes: a retrospective propensity score analysis in non-small-cell lung cancer
2020 · Yoshihiko Taniguchi, Akihiro Tamiya, et al. · BMJ Supportive & Palliative Care · 22
Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease
2021 · Naoko Okano, Nobuteru Kubo, et al. · Cancers · 21
PDF
Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer
2020 · Takatoshi Enomoto, Akihiro Tamiya, et al. · Clinical & Translational Oncology · 18
Association between lung ultrasound B‐lines and exercise‐induced pulmonary hypertension in patients with connective tissue disease
2021 · Kazuki Kagami, Tomonari Harada, et al. · Echocardiography · 16
PDF
Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study
2022 · Koichi Yamaguchi, Takahito Nakajima, et al. · Clinical Rheumatology · 13
Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients
2021 · Koichi Yamaguchi, Aya Yamaguchi, et al. · Rheumatology International · 12
Clinical differences among patients with myeloperoxidase–antineutrophil cytoplasmic antibody–positive interstitial lung disease
2022 · Koichi Yamaguchi, Aya Yamaguchi, et al. · Clinical Rheumatology · 11
Influence of obesity in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies
2022 · Koichi Yamaguchi, Yasuhiro Fukushima, et al. · Respiratory Medicine · 8
Retrospective analysis of long‐term survival factors in patients with advanced non‐small cell lung cancer treated with nivolumab
2022 · Yusuke Murakami, Akihiro Tamiya, et al. · Thoracic Cancer · 7
PDF
Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus
2021 · Masao Takemura, Mitsuru Motegi, et al. · Respiratory Medicine Case Reports · 7
PDF
Limitations of End-Tidal CO2 Measured with a Portable Capnometer to Estimate PaCO2 for Patients with Respiratory Disease
2021 · Takatoshi Enomoto, Yoshinobu Matsuda, et al. · Turkish Thoracic Journal · 5
Immunotherapy for NSCLC With Brain Metastases: What Can We Learn From Real-World Data?
2019 · Shunichi Kouno, Shinji Atagi · Journal of Thoracic Oncology · 4
PDF
Nivolumab treatment beyond progression disease in advanced non-small cell lung cancer
2019 · T. Enomoto, A. Tamiya, et al. · Annals of Oncology · 3
PDF
Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report
2020 · Yuji Inagaki, Akihiro Tamiya, et al. · Medicine · 2
Osimertinib-associated cardiac dysfunction in epidermal growth factor receptor-mutant non-small cell lung cancer: a single-center three-case series requiring hospitalization
2026 · Masao Takemura, Shun Inoue, et al. · Respiratory Medicine Case Reports · 1
Glasgow prognostic score and body mass index predict short-term discontinuation of the antifibrotic agents pirfenidone and nintedanib
2024 · Kazutaka Takehara, Yasuhiko Koga, et al. · Respiratory Investigation · 1
PDF
Meaningful Symptoms of Immune Checkpoint Inhibitor Therapy–Related Gastrointestinal Adverse Events in Patients With Inflammatory Bowel Disease
2020 · Yuji Inagaki, Kouji Azuma, et al. · Journal of Clinical Oncology · 1
Analysis of predictive factors in non-small cell lung cancer patients treated with nivolumab
2019 · K. Azuma, A. Tamiya, et al. · Annals of Oncology · 1
Rare Case of Fusobacterium necrophorum Bacteremia and Pleural Empyema Originating from a Burn Ulcer in a 16-Year-Old Female Patient
2024 · Masakiyo Yatomi, Chihiro Hashimoto, et al. · American Journal of Case Reports
Correction to: Nivolumab treatment beyond progressive disease in advanced non‑small cell lung cancer
2022 · Takatoshi Enomoto, Akihiro Tamiya, et al. · Clinical & Translational Oncology
A Case of Thymic Carcinoma That Achieved a Long-term Progression-free Survival by Radiation Therapy and Sequential Chemotherapy for Postoperative Intrathoracic Recurrence
2021 · Shunichi Kouno, Miki Itai, et al. · Haigan
PDF
P2.01-60 Analysis of Prognostic Factors According to Performance Status in Non-Small Cell Lung Cancer Patients Treated with Nivolumab
2019 · Y. Adachi, A. Tamiya, et al. · Journal of Thoracic Oncology
PDF
Works count: 24
Citation count: 277
H-index: 9
I10-index: 9
Year
Topic
Type